Figure 1From: Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis Comparison of NAb- and NAb + groups in terms of response to IFNβ treatment during the follow-up period. a. Mean number of relapse during follow-up period between NAb- and NAb + groups. b. EDSS variation during follow-up period between NAb- and NAb + groups. c. Number of responder and non responder in NAb- and NAb + groups. *p <0.05.Back to article page